CAS: 1121-22-8; Trans-Cyclohexane-1,2-Diamine

该化合物是一个双环有机化合物,其特点是存在两个附于环环上的地雷功能组,该化合物作为一种种族混合物存在,意思是两种对应体的同等数量,它们都是不可超越的镜像.该结构表明,这些地雷组位于环环的对面,有助于其独特的立体化学.它对于在室内温度下黄色的固体来说是无色的,在水和各种有机溶剂中是可溶的.这些矿组的存在允许氢结合,这可能影响其再活性和其他分子的相互作用. 跨-1-2-Dimammunicenah经常用于有机合成,特别是用于为协调化学和作为制药的建筑块而准备离子.它能够形成金属离子,因此在催化和材料科学中具有价值.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号71172-32-2 trans-1,2-dinit... | CAS号286-18-0 7-Aza-bicyclo[4... | CAS号2562-37-0 1-硝基环己烯 | CAS号108-45-2 间苯二胺 | CAS号110-83-8 环己烯 | CAS号492-99-9 1,2-环己二酮二肟 | CAS号931-16-8 (1R,2R)-(-)-2-氨基环己醇 | CAS号2802-07-5 (NE)-N-[(3E)-3-... | CAS号140926-77-8 1-N,2-N-bis(7-c... | CAS号20439-47-8 (1R,2R)-(-)-1,2-环己二胺 | CAS号21436-03-3 (1S,2S)-(+)-1,2-环己二胺 | CAS号186144-56-9 dimethyl 3,3'-(... | CAS号61848-66-6 二氯-1R,2R-1,2-环己二胺合铂 | CAS号13291-61-7 反式-1,2-环己二胺四乙酸

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-2024294464-A1
    优先权日:2021-10-27
    标题 :Synthesis of restrained complexing agents
    发明人:WONG NICHOLAS; GOSSELIN FRANCIS
    权利人:GENENTECH INC
    摘要:Improved methods of synthesis of a restrained complexing agent are described herein. Compounds, including salts and solvates thereof, and compositions relevant to the improved methods are also described.

    专利号:US-8735586-B2
    优先权日:2007-06-26
    标 题 :Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
    发明人:ALONSO JORGE; LINDENSCHMIDT ANDREAS; NAZARÉ MARC; URMANN MATTHIAS; HALLAND NIS; RKYEK OMAR
    权利人:ALONSO JORGE; LINDENSCHMIDT ANDREAS; NAZARÉ MARC; URMANN MATTHIAS; HALLAND NIS; RKYEK OMAR; SANOFI SA
    摘要:The present invention relates to a process for the regioselective synthesis of compounds of the formula I, n nwherein R0; R1; R2; R3; R4; R5; A1; A2; A3; A4, Q and J have the meanings indicated in the claims. The present invention provides a direct copper catalyzed regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted amides.

    专利号:US-2007249867-A1
    优先权日:2004-08-11
    标题 :Method for Synthesis of Aromatic Amine
    发明人:NAKASHIMA HARUE; KAWAKAMI SACHIKO
    权利人:NAKASHIMA HARUE; KAWAKAMI SACHIKO
    摘要:One embodiment of the present invention provides a method for synthesis of substituted secondary amine by the reaction of aniline with aryl halide by using a Pd catalyst including (t-Bu) 3 P as a ligand.

    专利号:US-7759492-B2
    优先权日:2004-08-20
    标 题:Enantioselective synthesis of 13-oxotricyclo[8.2.1.0.3,8] trideca-3(8),4,6-triene-5-carboxylates
    发明人:KEEN STEPHEN PHILIP; OLIVER STEVEN FRASER; STEWART GAVIN WILLIAM
    权利人:MERCK SHARP & DOHME
    摘要:An enantioselective route to compounds of formula I is disclosed: n n n n n n n n n n The compounds of formula I are key intermediates in the synthesis of compounds useful in treatment of Alzheimer's disease.

    专利号:US-9006425-B2
    优先权日:2009-03-18
    标题:Aluminum complexes and their use in the synthesis of cyclic carbonates
    发明人:NORTH MICHAEL
    权利人:NORTH MICHAEL; UNIV YORK
    摘要:Dimeric aluminum catalysts of formula I: and their use in catalyzing the synthesis of cyclic carbonates from epoxides and carbon dioxide.
    武汉裕清嘉衡药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jiahengpharma.com
    企业联系电话:15926260338👤
    📞武汉裕清嘉衡药业有限公司 ⚠️参考联系方式
    联系人:刘经理
    电话:15926260338
    手机:15926260338
    传真:027-83855312
    邮箱:2668571332@qq.com
    通信地址: 武汉市东西湖区金银湖街环湖中路A-2栋
    邮编: 430010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东西湖区金银湖街环湖中路A-2栋
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏清泉化学股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qqpharm.com
    企业联系电话:0571-86589381/2/3👤
    📞江苏清泉化学股份有限公司 ⚠️参考联系方式
    联系人:市场部
    电话:0571-86589381/2/3

    传真:0571-86589380
    邮箱:sales1@qqpharm.com
    通信地址: 江苏省盐城市滨海沿海化工园区
    邮编: 224555
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省盐城市滨海沿海化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉华玖医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.whhjpharm.com
    企业联系电话:18120446293👤
    📞武汉华玖医药科技有限公司 ⚠️参考联系方式
    联系人:汪经理
    电话:18120446293
    手机:18120446293
    传真:027-59220200
    邮箱:3504472216@qq.com
    通信地址: 武汉市东西湖区泾河办事处陈家岭189号
    邮编: 432000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:武汉市东西湖区泾河办事处陈家岭189号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1080/01635580903285106
    摘要:Patel BB, Majumdar APN. Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview. Nutrition and Cancer. 2009 Nov 10;61(6):842–6. doi: 10.1080/01635580903285106.
    参考文献:10.2174/157016210791111061
    摘要:Berretta M, Lleshi A, Cappellani A, Bearz A, Spina M, Talamini R, Cacopardo B, Nunnari G, Montesarchio V, Izzi I, Lanzafame M, Nasti G, Basile F, Berretta S, Fisichella R, Schiantarelli C C, Garlassi E, Ridolfo A, Guella L, Tirelli U. Oxaliplatin based chemotherapy and concomitant highly active antiretroviral therapy in the treatment of 24 patients with colorectal cancer and HIV infection. Curr HIV Res. 2010 Apr;8(3):218–22. doi: 10.2174/157016210791111061.
    参考文献:10.1007/s00280-005-0123-3
    摘要:Balin-Gauthier D, Delord JP, Rochaix P, Mallard V, Thomas F, Hennebelle I, Bugat R, Canal P, Allal C. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR. Cancer Chemother Pharmacol. 2006 Jun;57(6):709–18. doi: 10.1007/s00280-005-0123-3.
    参考文献:10.1186/1477-7819-9-70
    摘要:Wayne MG, Narang R, Chauhdry A, Steele J. Hepatic actinomycosis mimicking an isolated tumor recurrence. World Journal of Surgical Oncology. 2011 Jul 11;9(1):70. doi: 10.1186/1477-7819-9-70.
    摘要:Burney IA, Al-Moundhri MS. Major Advances in the Treatment of Cancer: What does a Non-Oncologist need to know Sultan Qaboos Univ Med J. 2008 Jul;8(2):137–48.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知